Home›Neurology› Navigated rTMS yields modest motor and disability gains in subacute and chronic stroke
Navigated rTMS yields modest motor and disability gains in subacute and chronic strokeNavigated Repetitive Transcranial Magnetic Stimulation Shows Promise for Stroke Recovery
Journal of clinical neuroscience : official journal of the Neurosurgical Society of AustralasiaPublished November 1, 2026Study authors: Beris Evangelos, Tsitsopoulos Parmenion P, Katsanos Aristeidis H, Bellos Stefanos, Simos Yannis V, L…PubMed ↗DOI ↗Editorial oversight: Dr. Ji-eun Park, MD · Brain, Mind & Pain
AI-generated summary of the cited source, checked by automated accuracy review.
How we work
Share
Key Takeaway
Consider navigated rTMS as a modest adjunct for motor recovery in subacute and chronic stroke, pending further trials.
This meta-analysis pooled data from 606 subacute and chronic stroke patients (active n=360, sham n=246) to evaluate the efficacy of navigated repetitive transcranial magnetic stimulation (rTMS) versus sham stimulation. The primary outcome was not specified, but motor and disability-related outcomes were assessed.
Navigated rTMS was associated with a modest but statistically significant overall benefit compared with sham (SMD 0.4, 95% CI 0.11-0.69). Disability-related outcomes showed a larger significant improvement (SMD 0.61, 95% CI 0.14-1.08). Among stimulation modalities, continuous theta-burst stimulation (TBS) produced the largest pooled effect, though effect size and statistical details were not reported.
The authors note that large comparative trials are needed to clarify the potential added value of navigated rTMS over conventional targeting approaches. Safety data, including adverse events and tolerability, were not reported. Follow-up duration and study setting were also not described. The evidence is associative, and causality cannot be inferred.
In practice, navigated rTMS may offer modest improvements in motor and disability outcomes for subacute and chronic stroke patients, but the limited evidence base and lack of safety reporting warrant cautious interpretation. Clinicians should consider these findings as preliminary and await further comparative trials.
How this fits prior evidence
This meta-analysis extends prior coverage of noninvasive brain stimulation after stroke, where three analytical pipelines identified validated and novel cortical targets, including the precuneus. It also aligns with the known gap in guideline-based stroke rehabilitation, which is delivered to only 35.6% of patients, by suggesting a neuromodulation approach that could complement rehabilitation. However, the modest effect sizes (SMD 0.4 overall, 0.61 for disability) and the need for large comparative trials highlight that navigated rTMS is not yet a proven add-on. The findings do not address the underdelivery of rehabilitation but offer a potential adjunct.
Researchers analyzed data from 606 patients who experienced subacute or chronic stroke. The study looked at the effects of navigated repetitive transcranial magnetic stimulation, known as rTMS, compared to a sham treatment. This type of treatment uses magnetic fields to target specific areas of the brain.
The results showed that navigated rTMS was more effective than sham treatment for improving motor outcomes. Patients also saw significant improvements in outcomes related to disability. Among the different types of stimulation used, continuous theta-burst stimulation showed the largest pooled effect.
While these results are positive, the evidence is currently limited. The study notes that more large comparative trials are needed to see if this specific method is better than standard targeting approaches. Because the evidence is not yet definitive, these findings should be discussed with a medical professional to see how they apply to specific cases.
What this means for you:
Navigated rTMS shows modest but significant improvements in motor and disability outcomes for stroke patients.
Common questions
What is navigated rTMS and how does it help stroke patients?
Navigated repetitive transcranial magnetic stimulation (rTMS) uses magnetic fields to target specific areas of the brain. In this study of 606 patients, this method was found to be more effective than sham treatment for improving motor outcomes and disability-related outcomes in those with subacute or chronic stroke.
Which type of stimulation was most effective?
The study looked at different stimulation modalities. It found that continuous theta-burst stimulation (TBS) had the largest pooled effect among the different types of stimulation methods tested for stroke patients.
Is this treatment better than standard stroke treatments?
The study shows that navigated rTMS is associated with improvements in motor and disability outcomes. However, more large trials are needed to determine if this method provides a specific advantage over conventional targeting approaches.
Repetitive transcranial magnetic stimulation (rTMS) is a subcategory of non-invasive brain stimulation (NIBS), used to modulate brain plasticity and improve post-stroke recovery. Neuronavigation is used to improve the accuracy of stimulation with the aim of achieving a superior clinical outcome than with conventional targeting. The objective of this review is to evaluate the efficacy of navigated rTMS in subacute and chronic stroke patients in comparison to sham stimulation. We conducted a systematic-review and meta-analysis of randomized controlled trials (RCTs) identified from Pubmed, Scopus and Cochrane CENTRAL. Trials employing neuronavigated rTMS were included of these five types; high and low frequency rTMS, intermittent and continuous theta-burst stimulation (TBS) and Hebbian-type stimulation. 13 RCTs were included after a screening of 1900 studies. 606 patients receiving either active (n = 360) or sham stimulation (n = 246) were assessed. The pooled standardized mean difference (SMD) favored rTMS over sham SMD = 0.4 (95 %CI: 0.11-0.69), with moderate heterogeneity I = 55 %. Among stimulation modalities, continuous TBS showed the largest pooled effect. rTMS was also associated with significant improvements in disability-related outcomes, SMD = 0.61 (95 % CI 0.14-1.08). Navigated rTMS is associated with modest but significant improvements in motor and disability outcomes in subacute and chronic stroke. Large comparative trials are required to clarify the potential added value over conventional targeting approaches.
